Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55